×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share

PROGRAMME:

Modérateurs: Fabrice Lécuru et Manuel Rodrigues
19:00
Spécificités des soins de support en ovaire : gestion de la carcinose symptomatique et pré-habilitation en néoadjuvant
Carole Bouleuc
 
 
19:15
Quel avenir à l’immunothérapie dans les cancers de l’ovaire ?
Audrey Bellesoeur
 
19:30
Traitement des récidives sous PARPi
Manuel Rodrigues
 
19:45
Chirurgie de la récidive : au-delà des essais GOG213, SOC1 & DESKTOP
Fabrice Lécuru
 
 
20:00
Débat/Discussion - Réponses aux questions
 
 
  
Shooting date : 2022-03-22
Last update : 2022-03-24
1 comment
Join the Discussion
  • johanne L. bonjour comment fait-on pour s inscrire ?

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    Suggestions

    Wednesday, January 22nd 2025 from 06pm to 07pm (GMT+1)
    Honolulu : Wednesday, January 22nd 2025 from 06am to 07am (GMT+1)
    San Francisco : Wednesday, January 22nd 2025 from 08am to 09am (GMT+1)
    New York : Wednesday, January 22nd 2025 from 11am to 12pm (GMT+1)
    Buenos Aires : Wednesday, January 22nd 2025 from 01pm to 02pm (GMT+1)
    London / Dublin : Wednesday, January 22nd 2025 from 04pm to 05pm (GMT+1)
    Paris / Berlin : Wednesday, January 22nd 2025 from 05pm to 06pm (GMT+1)
    Istanbul : Wednesday, January 22nd 2025 from 06pm to 07pm (GMT+1)
    Moscou / Dubaï : Wednesday, January 22nd 2025 from 08pm to 09pm (GMT+1)
    Bangkok : Wednesday, January 22nd 2025 from 11pm to 12am (GMT+1)
    Shanghai : Thursday, January 23rd 2025 from 12am to 01am (GMT+1)
    Tokyo : Thursday, January 23rd 2025 from 01am to 02am (GMT+1)
    Sydney : Thursday, January 23rd 2025 from 02am to 03am (GMT+1)
    Wellington : Thursday, January 23rd 2025 from 04am to 05am (GMT+1)

    Prise en charge des cancers de l'ovaire en rechute :

    état des lieux et perspectives

    Share
    Tuesday, April 29th 2025 from 01pm to 01:45pm (GMT+2)
    Honolulu : Tuesday, April 29th 2025 from 01am to 01:45am (GMT+2)
    San Francisco : Tuesday, April 29th 2025 from 04am to 04:45am (GMT+2)
    New York : Tuesday, April 29th 2025 from 07am to 07:45am (GMT+2)
    Buenos Aires : Tuesday, April 29th 2025 from 08am to 08:45am (GMT+2)
    Reykjavik : Tuesday, April 29th 2025 from 11am to 11:45am (GMT+2)
    London / Dublin : Tuesday, April 29th 2025 from 12pm to 12:45pm (GMT+2)
    Paris / Berlin : Tuesday, April 29th 2025 from 01pm to 01:45pm (GMT+2)
    Istanbul : Tuesday, April 29th 2025 from 02pm to 02:45pm (GMT+2)
    Moscou / Dubaï : Tuesday, April 29th 2025 from 03pm to 03:45pm (GMT+2)
    Bangkok : Tuesday, April 29th 2025 from 06pm to 06:45pm (GMT+2)
    Shanghai : Tuesday, April 29th 2025 from 07pm to 07:45pm (GMT+2)
    Tokyo : Tuesday, April 29th 2025 from 08pm to 08:45pm (GMT+2)
    Sydney : Tuesday, April 29th 2025 from 10pm to 10:45pm (GMT+2)
    Wellington : Wednesday, April 30th 2025 from 12am to 12:45am (GMT+2)

    Comment prendre en charge un cancer de l'endomètre avancé ?

    Cancer de l’endomètre avancé pMMR NSMP (épisode 4)

    Share
    Wednesday, June 11th 2025 from 12pm to 01pm (GMT+2)
    Honolulu : Wednesday, June 11th 2025 from 12am to 01am (GMT+2)
    San Francisco : Wednesday, June 11th 2025 from 03am to 04am (GMT+2)
    New York : Wednesday, June 11th 2025 from 06am to 07am (GMT+2)
    Buenos Aires : Wednesday, June 11th 2025 from 07am to 08am (GMT+2)
    Reykjavik : Wednesday, June 11th 2025 from 10am to 11am (GMT+2)
    London / Dublin : Wednesday, June 11th 2025 from 11am to 12pm (GMT+2)
    Paris / Berlin : Wednesday, June 11th 2025 from 12pm to 01pm (GMT+2)
    Istanbul : Wednesday, June 11th 2025 from 01pm to 02pm (GMT+2)
    Moscou / Dubaï : Wednesday, June 11th 2025 from 02pm to 03pm (GMT+2)
    Bangkok : Wednesday, June 11th 2025 from 05pm to 06pm (GMT+2)
    Shanghai : Wednesday, June 11th 2025 from 06pm to 07pm (GMT+2)
    Tokyo : Wednesday, June 11th 2025 from 07pm to 08pm (GMT+2)
    Sydney : Wednesday, June 11th 2025 from 09pm to 10pm (GMT+2)
    Wellington : Wednesday, June 11th 2025 from 11pm to 12am (GMT+2)

    Recommandations de Saint Paul de Vence 2025

    Focus cancer de l’endomètre avancé ou en rechute

    Share
    Tuesday, December 13th 2022 from 06pm to 07:30pm (GMT+1)
    Honolulu : Tuesday, December 13th 2022 from 06am to 07:30am (GMT+1)
    San Francisco : Tuesday, December 13th 2022 from 08am to 09:30am (GMT+1)
    New York : Tuesday, December 13th 2022 from 11am to 12:30pm (GMT+1)
    Buenos Aires : Tuesday, December 13th 2022 from 01pm to 02:30pm (GMT+1)
    London / Dublin : Tuesday, December 13th 2022 from 04pm to 05:30pm (GMT+1)
    Paris / Berlin : Tuesday, December 13th 2022 from 05pm to 06:30pm (GMT+1)
    Istanbul : Tuesday, December 13th 2022 from 06pm to 07:30pm (GMT+1)
    Moscou / Dubaï : Tuesday, December 13th 2022 from 08pm to 09:30pm (GMT+1)
    Bangkok : Tuesday, December 13th 2022 from 11pm to 12:30am (GMT+1)
    Shanghai : Wednesday, December 14th 2022 from 12am to 01:30am (GMT+1)
    Tokyo : Wednesday, December 14th 2022 from 01am to 02:30am (GMT+1)
    Sydney : Wednesday, December 14th 2022 from 02am to 03:30am (GMT+1)
    Wellington : Wednesday, December 14th 2022 from 04am to 05:30am (GMT+1)

    Last improvements in advanced ovarian cancer treatment

    Trials that have or will impact practices in the management of patients with advanced ovarian cancer

    Share
    Scroll Up